CTLA4 and cancer: While monoclonal antibodies targeting CTLA4 have found applications in treating cancers like kidney and lung malignancies [18, 19], the connection between Triple-Negative Breast Cancer Stem Cells (TN-BCSCs) and CTLA4 remains inadequately elucidated.